Genetic association of cholesterol metabolism with the risk of depression and schizophrenia
Acta Neuropsychiatrica · 2024
DOI: 10.1017/neu.2024.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropsychiatrica, 2024. Verfasst von Zheng Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Haihe Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Schizophrenia, Cholesterol, Genome-Wide Association Study, Mendelian Randomization Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Themen: Depression
Abstract (Originalsprache)
Objective
Some observational studies have unexpectedly reported the association of cholesterol metabolism with mental and psychological disorders, but a firm conclusion has not been drawn. The aim of this study was to further investigate the effects of peripheral cholesterol traits and cholesterol-lowering therapy on depression and schizophrenia using a Mendelian randomisation approach.
Methods
Instrumental variables meeting the correlation, independence and exclusivity assumptions were extracted from one genome-wide association study for predicting total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and nonHDL cholesterol. Instrumental variables for total cholesterol and LDL cholesterol were also adopted to predict statin use (a type of cholesterol-lowering drug); these instrumental variables should not only satisfy the above assumptions but also be close to 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR, the target gene of statins) on the chromosome. Three methods (including inverse variance weighted) were used to conduct causal inference of the above exposures with depression and schizophrenia. Sensitivity analyses were performed to assess horizontal pleiotropy.
Results
Higher levels of peripheral nonHDL cholesterol were nominally associated with a decreased risk of depression ( P = 0.039), and higher levels of HMGCR-mediated total cholesterol and LDL cholesterol were nominally related to a decreased risk of depression ( P = 0.013 and P = 0.028, respectively). Moreover, these cholesterol traits cannot affect the risk of schizophrenia. Sensitivity analysis did not reveal any horizontal pleiotropy.
Conclusion
The study provided some interesting, but less sufficient, evidence that nonHDL cholesterol may have a protective effect on depression, and lowering cholesterol using statins might increase the risk of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Haihe Hospital, Tianjin, China.
- Department of Child and Adolescent Psychology, Tianjin Anding Hospital, Tianjin, China.
- Department of Rehabilitation, Tianjin Anding Hospital, Tianjin, China.
- Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Zheng Chen, Feng Wang
Zitieren
APA
Chen, Z., Sui, G., Yang, C., Lv, Z., & Wang, F. (2024). Genetic association of cholesterol metabolism with the risk of depression and schizophrenia. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2024.26
Vancouver
Chen Z, Sui G, Yang C, Lv Z, Wang F. Genetic association of cholesterol metabolism with the risk of depression and schizophrenia. Acta Neuropsychiatrica. 2024. doi:10.1017/neu.2024.26
BibTeX
@article{Chen2024,
author = {Chen, Zheng and Sui, Guanghong and Yang, Caixia and Lv, Zongshun and Wang, Feng},
title = {Genetic association of cholesterol metabolism with the risk of depression and schizophrenia},
journal = {Acta Neuropsychiatrica},
year = {2024},
doi = {10.1017/neu.2024.26}
}
EUVIMED